| Application no. and date | 14702977.1 (espacenet) (Federated) (European Patent Register), 20140109 | | Patent/reg. no. and date | DK/EP 2943185, 20201118 | | Publication date | 20151118 | | Priority no. and date | US 201361750797 P, 20130109, US 201361762833 P, 20130208 | | EP pub. no. and date |
EP 2943185 20151118 | | Effective date | | | Applicant/owner | Edgemont Pharmaceuticals, LLC Liquidating Trust, 1037 Raymond Blvd., Suite 1520
Newark, NJ 07102, US | | Applicant ref. no. | P75410DK01 | | Inventor | SALTEL, Douglas A., c/o Edgemont Pharmaceuticals
1250 Capital of Texas Hwy
South Building 3
Suite 400
Austin, Texas 78746, US,
VACHON, Michael, c/o Edgemont Pharmaceuticals
1250 Capital of Texas Hwy
South Building 3
Suite 400
Austin, Texas 78746, US | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 31/5513 (2006.01) , A61K 9/16 (2006.01) , A61K 9/50 (2006.01) , A61P 25/22 (2006.01) , A61P 25/24 (2006.01) | | Title | FORMULERINGER MED LANGVARIG FRIGIVELSE AF LORAZEPAM | | Int. application no. | US2014010854 | | Int. publication no. | WO2014110245 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
